1、2020/10/1812020/10/1822020/10/1832020/10/1842020/10/185H3COH3COCCNCH(CH3)2(CH2)3OCH3OCH3CH2CH2CH3NNSOCOCH3OCH3OCH2CH2N(CH3)22020/10/186NO2HNCOOCH3H3COOCCH3H3CH2020/10/1872020/10/1882020/10/1892020/10/18102020/10/18112020/10/1812CH3NHCH3COCH2NC2H5C2H52020/10/1813CCNHCNHOO2020/10/18142020/10/1815CH2CH
2、 CH2OHNHCH(CH3)2O2020/10/1816OCOCH2CH2CH2CH3OIICH2CH2NC2H5C2H52020/10/1817H3COH3COCCNCH(CH3)2(CH2)3OCH3OCH3CH2CH2CH3N2020/10/18182020/10/1819OCH3HOOHOCH3OOHOHOO13691217142020/10/18202020/10/18212020/10/18222020/10/18232020/10/18242020/10/18252020/10/18262020/10/18272020/10/1828CH2CHCH2OOONO2NO2NO220
3、20/10/18292020/10/1830CH2CH CH2OHNHCH(CH3)2O2020/10/18312020/10/18322020/10/18332020/10/18342020/10/18352020/10/18362020/10/18372020/10/18382020/10/18392020/10/18402020/10/1841NNNHHClCl2020/10/18422020/10/18432020/10/18442020/10/18451 受体1 受体阻断药阻断药肼屈嗪等肼屈嗪等2020/10/18462020/10/1847ClNHCOOHH2NO2SCH2O2020/10/1848R6H2NO2SNHCHNSO2R3R21234672020/10/1849NNNNH2NNH2NH22020/10/1850谢谢您的聆听与观看THANK YOU FOR YOUR GUIDANCE.感谢阅读！为了方便学习和使用，本文档的内容可以在下载后随意修改，调整和打印。欢迎下载！汇报人：XXX日期：20XX年XX月XX日
